ClinicalTrials.Veeva

Find clinical trials for Glioblastoma (GBM) in Aurora, CO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Recurrence
Brain Cancer
Glioma
Astrocytoma
Cancer
Gliosarcoma

Glioblastoma (GBM) trials near Aurora, CO, USA:

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

The primary purpose of the study is to determine the efficacy of an investigational therapy called DCVax(R)-L in patients with newly diagnosed GBM...

Active, not recruiting
Glioblastoma
Glioblastoma Multiforme
Drug: Dendritic cell immunotherapy

Phase 3

Northwest Biotherapeutics
Northwest Biotherapeutics

Aurora, Colorado, United States and 85 other locations

Locations recently updated

Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....

Enrolling
Glioblastoma
Biological: ADI-PEG 20
Drug: VT1021

Phase 2, Phase 3

Global Coalition for Adaptive Research

Aurora, Colorado, United States and 60 other locations

OKN-007 combined with temozolomide(TMZ) in patients with recurrent glioblastoma(GBM). All patients will have been previously treate...

Active, not recruiting
Brain Glioblastoma
Recurrent Malignant Glioma
Drug: Temozolomide (TMZ)
Drug: OKN-007

Phase 2

Oblato

Englewood, Colorado, United States and 12 other locations

To test the effectiveness and safety of Optune® given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM...

Active, not recruiting
Glioblastoma Multiforme
Device: Optune®
NovoCure
NovoCure

Aurora, Colorado, United States and 132 other locations

(TNBC), ovarian cancer, gastric cancer, colorectal cancer (CRC), glioblastoma (GBM), biliary tract cancers (BTC), or pancreatic can...

Active, not recruiting
Glioblastoma
Gastric Cancer
Biological: Pembrolizumab
Drug: Lenvatinib

Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Aurora, Colorado, United States and 87 other locations

This is an open-label, two-part, phase 1-2 dose-finding study designed to determine the safety, tolerability, PK, PD, and proof-of-concept efficacy o...

Enrolling
Glioblastoma
Glioblastoma Multiforme
Drug: Temozolomide
Drug: ST101

Phase 1, Phase 2

Sapience Therapeutics

Denver, Colorado, United States and 11 other locations

Researchers are looking for a better way to treat people with solid tumors. Before a treatment can be approved for people to take, researchers do cli...

Active, not recruiting
Solid Tumors
Drug: Regorafenib, (Stivarga, BAY73-4506)
Drug: Nivolumab (Opdivo)

Phase 2

Bayer
Bayer

Aurora, Colorado, United States and 33 other locations

This is an open-label, multicenter, randomized, parallel, 2-arm, efficacy and safety study. Patients with GBM after failure of standard firs...

Active, not recruiting
Glioblastoma Multiforme, Adult
Drug: Berubicin
Drug: Lomustine

Phase 2

CNS Pharmaceuticals
CNS Pharmaceuticals

Englewood, Colorado, United States and 55 other locations

alone versus bevacizumab in patients diagnosed with recurrent glioblastoma (a type of brain cancer, also known as GBM), and to eval...

Active, not recruiting
Recurrent Glioblastoma
Biological: Nivolumab
Biological: Ipilimumab

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Aurora, Colorado, United States and 112 other locations

receptor (EGFR) resistance (EGFR C797S) mutations with or without CNS disease (in Phase 1 and Phase 2), or glioblastoma multiforme (GBM...

Enrolling
Advanced Non-Small Cell Squamous Lung Cancer
Epidermal Growth Factor Receptor C797S
Drug: BDTX-1535 monotherapy

Phase 1, Phase 2

Black Diamond Therapeutics

Denver, Colorado, United States and 25 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems